Literature DB >> 32533200

Gene-environment regulation of chamber-specific maturation during hypoxemic perinatal circulatory transition.

Yan Zhao1,2, Xuedong Kang1,2, Alexander Barsegian1,2, Jian He1,2, Alejandra Guzman1,2, Ryan P Lau3, Reshma Biniwale4, Madhuri Wadhra3, Brian Reemtsen4, Meena Garg1, Nancy Halnon1, Fabiola Quintero-Rivera3, Wayne W Grody3, Glen Van Arsdell4, Stanley F Nelson1,5,6,7, Marlin Touma8,9,10,11,12,13,14.   

Abstract

Chamber-specific and temporally regulated perinatal cardiac growth and maturation is critical for functional adaptation of the heart and may be altered significantly in response to perinatal stress, such as systemic hypoxia (hypoxemia), leading to significant pathology, even mortality. Understanding transcriptome regulation of neonatal heart chambers in response to hypoxemia is necessary to develop chamber-specific therapies for infants with cyanotic congenital heart defects (CHDs). We sought to determine chamber-specific transcriptome programming during hypoxemic perinatal circulatory transition. We performed transcriptome-wide analysis on right ventricle (RV) and left ventricle (LV) of postnatal day 3 (P3) mouse hearts exposed to perinatal hypoxemia. Hypoxemia decreased baseline differences between RV and LV leading to significant attenuation of ventricular patterning (AVP), which involved several molecular pathways, including Wnt signaling suppression and cell cycle induction. Notably, robust changes in RV transcriptome in hypoxemic condition contributed significantly to the AVP. Remarkably, suppression of epithelial mesenchymal transition (EMT) and dysregulation of the TP53 signaling were prominent hallmarks of the AVP genes in neonatal mouse heart. Furthermore, members of the TP53-related gene family were dysregulated in the hypoxemic RVs of neonatal mouse and cyanotic Tetralogy of Fallot hearts. Integrated analysis of chamber-specific transcriptome revealed hypoxemia-specific changes that were more robust in RVs compared with LVs, leading to previously uncharacterized AVP induced by perinatal hypoxemia. Remarkably, reprogramming of EMT process and dysregulation of the TP53 network contributed to transcriptome remodeling of neonatal heart during hypoxemic circulatory transition. These insights may enhance our understanding of hypoxemia-induced pathogenesis in newborn infants with cyanotic CHD phenotypes. KEY MESSAGES: During perinatal circulatory transition, transcriptome programming is a major driving force of cardiac chamber-specific maturation and adaptation to hemodynamic load and external environment. During hypoxemic perinatal transition, transcriptome reprogramming may affect chamber-specific growth and development, particularly in newborns with congenital heart defects (CHDs). Chamber-specific transcriptome changes during hypoxemic perinatal transition are yet to be fully elucidated. Systems-based analysis of hypoxemic neonatal hearts at postnatal day 3 reveals chamber-specific transcriptome signatures during hypoxemic perinatal transition, which involve attenuation of ventricular patterning (AVP) and repression of epithelial mesenchymal transition (EMT). Key regulatory circuits involved in hypoxemia response were identified including suppression of Wnt signaling, induction of cellular proliferation and dysregulation of TP53 network.

Entities:  

Keywords:  Congenital heart defects; Hypoxia; Neonatal heart maturation; Tetralogy of Fallot; Transcriptome

Mesh:

Year:  2020        PMID: 32533200      PMCID: PMC7843236          DOI: 10.1007/s00109-020-01933-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  33 in total

1.  A chemosensitization screen identifies TP53RK, a kinase that restrains apoptosis after mitotic stress.

Authors:  David Peterson; James Lee; Xingye C Lei; William F Forrest; David P Davis; Peter K Jackson; Lisa D Belmont
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

Review 2.  Fetal-to-neonatal maladaptation.

Authors:  Sunil K Sinha; Steven M Donn
Journal:  Semin Fetal Neonatal Med       Date:  2006-03-27       Impact factor: 3.926

Review 3.  Cardiac repair by epicardial EMT: Current targets and a potential role for the primary cilium.

Authors:  Jessica N Blom; Qingping Feng
Journal:  Pharmacol Ther       Date:  2018-01-17       Impact factor: 12.310

4.  Decoding the Long Noncoding RNA During Cardiac Maturation: A Roadmap for Functional Discovery.

Authors:  Xuedong Kang; Yan Zhao; Marlin Touma; Ashley A Cass; Fuying Gao; Reshma Biniwale; Giovanni Coppola; Xinshu Xiao; Brian Reemtsen; Yibin Wang
Journal:  Circ Cardiovasc Genet       Date:  2016-09-02

5.  p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis.

Authors:  S Okamura; H Arakawa; T Tanaka; H Nakanishi; C C Ng; Y Taya; M Monden; Y Nakamura
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

Review 6.  Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease.

Authors:  Alexander von Gise; William T Pu
Journal:  Circ Res       Date:  2012-06-08       Impact factor: 17.367

7.  Hypoxia induces heart regeneration in adult mice.

Authors:  Yuji Nakada; Diana C Canseco; SuWannee Thet; Salim Abdisalaam; Aroumougame Asaithamby; Celio X Santos; Ajay M Shah; Hua Zhang; James E Faber; Michael T Kinter; Luke I Szweda; Chao Xing; Zeping Hu; Ralph J Deberardinis; Gabriele Schiattarella; Joseph A Hill; Orhan Oz; Zhigang Lu; Cheng Cheng Zhang; Wataru Kimura; Hesham A Sadek
Journal:  Nature       Date:  2016-10-31       Impact factor: 49.962

8.  DOR/Tp53inp2 and Tp53inp1 constitute a metazoan gene family encoding dual regulators of autophagy and transcription.

Authors:  Ana Sancho; Jordi Duran; Antonio García-España; Caroline Mauvezin; Endalkachew A Alemu; Trond Lamark; Maria J Macias; Rob DeSalle; Miriam Royo; David Sala; Javier U Chicote; Manuel Palacín; Terje Johansen; Antonio Zorzano
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

Review 9.  A Path to Implement Precision Child Health Cardiovascular Medicine.

Authors:  Marlin Touma; Brian Reemtsen; Nancy Halnon; Juan Alejos; J Paul Finn; Stanley F Nelson; Yibin Wang
Journal:  Front Cardiovasc Med       Date:  2017-06-01

Review 10.  Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia.

Authors:  Jennifer E Ziello; Ion S Jovin; Yan Huang
Journal:  Yale J Biol Med       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.